We are live on ! Find out more
LRMR icon

Larimar Therapeutics
LRMR

162 hedge funds and large institutions have $395M invested in Larimar Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more call options, than puts

Call options by funds: $5.46M | Put options by funds: $1.67M

187% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 15

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

43% more capital invested

Capital invested by funds: $277M → $395M (+$118M)

19% more funds holding

Funds holding: 136 → 162 (+26)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.47% less ownership

Funds ownership: 84.95% → 84.48% (-0.47%)

Holders
162
Holders Change
+26
Holders Change %
+19.12%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
43
Increased
59
Reduced
41
Closed
15
Calls
$5.46M
Puts
$1.67M
Net Calls
+$3.79M
Net Calls Change
+$3.18M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$20M
2
DCM
Driehaus Capital Management
Illinois
+$9.59M
3
DTC
Deep Track Capital
Connecticut
+$6M
4
DCM
DAFNA Capital Management
California
+$4.36M
5
SCM
Soleus Capital Management
Connecticut
+$4.26M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$6.5M
2
Millennium Management
Millennium Management
New York
-$6.32M
3
Citadel Advisors
Citadel Advisors
Florida
-$3.39M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$2.16M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
151
Quantbot Technologies
New York
$1.49K +$1.32K +331 New
RIL
152
Rothschild Investment LLC
Illinois
$1.29K +$652 +163 +131%
RWM
153
Rialto Wealth Management
New York
$1.17K – – –
PWA
154
Physician Wealth Advisors
Utah
$1.05K – – –
PA
155
Parallel Advisors
California
$869 – – –
AAP
156
Arax Advisory Partners
Colorado
$707 +$588 +147 +1,470%
IA
157
IFP Advisors
Florida
$698 -$240 -60 -28%
FFO
158
Fortitude Family Office
Arizona
$666 +$592 +148 New
SIC
159
SJS Investment Consulting
Ohio
$140 +$124 +31 New
PNC Financial Services Group
160
PNC Financial Services Group
Pennsylvania
$77 – – –
WPA
161
Wealth Preservation Advisors
Tennessee
$45 +$40 +10 New
TPWA
162
Twin Peaks Wealth Advisors
California
$9 +$8 +2 New
Verition Fund Management
163
Verition Fund Management
Connecticut
– -$2.16M -567,683 Closed
GCP
164
GSA Capital Partners
United Kingdom
– -$389K -102,039 Closed
Two Sigma Advisers
165
Two Sigma Advisers
New York
– -$340K -89,124 Closed
QC
166
Quadrature Capital
United Kingdom
– -$220K -57,646 Closed
PFCS
167
Pale Fire Capital SE
Czech Republic
– -$172K -45,218 Closed
Man Group
168
Man Group
United Kingdom
– -$149K -39,225 Closed
Simplex Trading
169
Simplex Trading
Illinois
– -$122K -30,522 Closed
Squarepoint
170
Squarepoint
New York
– -$116K -30,416 Closed
CCM
171
Coldstream Capital Management
Washington
– -$62.2K -16,334 Closed
SG Americas Securities
172
SG Americas Securities
New York
– -$60K -15,757 Closed
SA
173
Strategic Advocates
Utah
– -$9.19K -2,350 Closed
AB
174
Amalgamated Bank
New York
– -$6K -1,527 Closed
BIA
175
Bell Investment Advisors
California
– -$2.95K -773 Closed
4 5 6
7
8

LRMR Hedge Fund Activity: Q1 2026 in Review

162 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q1 2026, worth a combined $395M — up 43% from $277M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new LRMR positions and 15 closed out — a net gain of 28 holders — while 59 added to existing stakes and 41 trimmed.

The largest buyer was Deerfield Management, adding an estimated $20M. The largest seller was RTW Investments, cutting an estimated $6.5M.

  • 162 institutional investors held Larimar Therapeutics (LRMR) as of Q1 2026, up from 136 in Q4 2025.
  • Funds reported $395M of Larimar Therapeutics stock for Q1 2026, up 43% quarter-over-quarter.
  • 43 funds opened new Larimar Therapeutics positions in Q1 2026 and 15 closed out, a net change of +28 holders.
  • The largest Larimar Therapeutics buyer in Q1 2026 was Deerfield Management, an estimated $20M added.
  • The largest Larimar Therapeutics seller in Q1 2026 was RTW Investments, an estimated $6.5M sold.

Based on aggregated 13F filings for Q1 2026.